0.46200001 EUR
0.0145
3.04%
Last update Dec 15, 7:35 PM CET
Main market
Day range
0.46000001
0.47799999
Previous close
0.47650000
Open
0.47799999
Access this stock data via API
Subscribe
Oncopeptides AB
0.46
0.01
3.04%

Financials

Income statement

Fundamentals currency is SEK
Fiscal date 2024 2023 2022 2021
Total reported revenue 2.9M 35.2M 8.4M 118.3M
Cost of revenue 244.8K -1.1M 6K 53.1M
Gross profit 2.7M 36.3M 8.3M 65.2M
Operating expense
Research & development 11.1M 106.9M 217.7M 679.9M
Selling general and admin 18.1M 188.5M 142.2M 873.8M
Other operating expenses -550.2K 1.4M 3.9M
Operating income -26.2M -254.5M -352.1M -1.4B
Non operating interest income
Income 753.5K 8.6M 2.6M 492K
Expense 1.2M 5.8M 883K 948K
Other income expense
Pretax income -26.1M -248.4M -337.7M -1.4B
Tax provision 36.6K 664K 271K 8.9M
Net income -26.2M -249.1M -338.0M -1.4B
Basic EPS -1.6 -2.0 -2.9 -13.5
Diluted EPS -1.6 -2.0 -2.9 -13.5
Basic average shares 16.2M 1.4B 1.3B 1.2B
Diluted average shares 16.2M 1.4B 1.3B 1.2B
EBITDA -24.1M -231.6M -319.6M -1.4B
Net income from continuing op. -26.1M -253.4M -349.4M -1.4B
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 43 minutes

10:16
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).